by Clinical Neuropsychologist | Thursday, August 29, 2024 | Dementia
Abstract Many coronavirus disease 2019 (COVID-19) positive individuals exhibit abnormal electroencephalographic (EEG) activity reflecting “brain fog” and mild cognitive impairments even months after the acute phase of infection. Resting-state EEG abnormalities include...
by Clinical Neuropsychologist | Wednesday, August 28, 2024 | Dementia
Abstract INTRODUCTION We investigated blood DNA methylation patterns associated with 15 well-established cerebrospinal fluid (CSF) biomarkers of Alzheimer’s disease (AD) pathophysiology, neuroinflammation, and neurodegeneration. METHODS We assessed DNA...
by Clinical Neuropsychologist | Wednesday, August 28, 2024 | Dementia
Abstract INTRODUCTION The established link between DNA methylation and pathophysiology of dementia, along with its potential role as a molecular mediator of lifestyle and environmental influences, positions blood-derived DNA methylation as a promising tool for early...
by Clinical Neuropsychologist | Wednesday, August 28, 2024 | Dementia
Abstract INTRODUCTION Typical Alzheimer’s disease (AD) and limbic-predominant age-related TAR DNA-binding protein 43 (TDP-43) encephalopathy (LATE) are two neurodegenerative diseases that present with a similar initial amnestic clinical phenotype but are...
by Clinical Neuropsychologist | Wednesday, August 28, 2024 | Dementia
Abstract INTRODUCTION The role of information processing speed (IPS) on relationships between episodic memory (EM) and central remodeling features in amnestic mild cognitive impairment (aMCI) was investigated. METHODS Neuropsychological evaluations and multimodal...
